-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Honored as One of the Top 100 Enterprises in National Traditional Medicine Brand Building for the Year
Category:
发布时间：2024-12-28
【概要描述】
Recently, the National Pharmaceutical Supply Chain Enterprises Exchange Conference, organized by the Pharmaceutical Industry Chamber of the All-China Federation of Industry and Commerce, was held in Shenyang. During the conference, the 2023–2024 List of the Top 100 Enterprises in National Pharmaceutical Brand Building was unveiled. Shijiazhuang Sihua Pharmaceutical was recognized as one of the “Top 100 Enterprises in National Pharmaceutical Brand Building,” marking another encouraging achievement for the company in brand development following its designation as a “Time-Honored Brand of Hebei.”
Recently, the National Pharmaceutical Supply Chain Enterprises Exchange Conference, organized by the Pharmaceutical Industry Chamber of the All-China Federation of Industry and Commerce, was held in Shenyang. During the conference, the 2023–2024 List of the Top 100 Enterprises in National Pharmaceutical Brand Building was unveiled. Shijiazhuang Sihua Pharmaceutical was honored as one of the “Top 100 Enterprises in National Pharmaceutical Brand Building,” marking another encouraging achievement in brand development for the company following its recognition as a “Time-Honored Brand of Hebei.”
As one of China’s top 100 pharmaceutical companies, Shijiazhuang Sihua Pharmaceutical has steadfastly upheld its original mission of “producing high-quality medicines for the people.” The company is committed to researching, developing, and manufacturing more “Chinese medicines” that are tailored to the genetic heritage and physical characteristics of the Chinese population, while placing great emphasis on the inheritance, innovation, and development of traditional Chinese medicine. In recent years, while deepening its expertise in specialty and innovative chemical drug formulations and active pharmaceutical ingredients, Shijiazhuang Sihua has also vigorously explored indigenous medicinal resources and actively pursued the R&D of traditional Chinese medicines. Through the implementation of “modernization of traditional Chinese medicine,” the company has continuously enhanced product quality control, ensuring that its indigenous medicine brands remain vibrant and competitive.
According to available information, the selection of the “Top 100 Enterprises for National Medicine Brand Building” focuses on national medicine brands as the primary evaluation subject. The assessment comprehensively evaluates applicant companies based on factors such as market sales revenue, industry share, brand awareness, technological innovation, degree of internationalization, and the enterprises’ specialized, refined, distinctive, and innovative characteristics. The initiative aims to promote national medicine, build national brands, establish industry benchmarks, serve as role models, and foster the healthy development of the national medicine industry.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091